Articles published by RefleXion Medical, Inc.

RefleXion Announces World’s First Single-Plan Multi-Modality Radiotherapy to Patient with Stage 4 Cancer at Yale New Haven Health

September 05, 2024

From RefleXion Medical, Inc.

Via Business Wire

RefleXion to Present at 2024 Jefferies Global Healthcare Conference

June 04, 2024

From RefleXion Medical, Inc.

Via Business Wire

RefleXion and Limbus AI Announce Technology Integration to Expedite Cancer Treatment Planning

March 28, 2024

From RefleXion Medical, Inc.

Via Business Wire

CMS Assigns Accretive Reimbursement for RefleXion’s Breakthrough SCINTIX Therapy

January 11, 2024

From RefleXion Medical, Inc.

Via Business Wire

RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers Including Brain, Pancreatic and Liver

September 20, 2023

From RefleXion Medical, Inc.

Via Business Wire

RefleXion Highlights Clinical Study Results for Future Prostate Cancer Treatment

June 26, 2023

From RefleXion Medical, Inc.

Via Business Wire

RefleXion Announces Installation of X1 Platform at Smilow Cancer Hospital at Yale New Haven

March 01, 2023

From RefleXion Medical, Inc.

Via Business Wire

RefleXion Receives Breakthrough Device Designation for Lung Cancer Treatment

December 01, 2021

From RefleXion Medical, Inc.

Via Business Wire

RefleXion Announces New Additions to Board of Directors and Appoints Audit Committee Chair

May 27, 2021

From RefleXion Medical, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.